Literature DB >> 26597615

Prostate cancer: Elective pelvic nodal radiotherapy: is the jury still out?

Juanita Crook1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26597615     DOI： 10.1038/nrurol.2015.283

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  4 in total

Review 1.  Pelvic nodal radiotherapy in patients with unfavorable intermediate and high-risk prostate cancer: evidence, rationale, and future directions.

Authors:  Lisa K Morikawa; Mack Roach
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-05-01       Impact factor: 7.038

2.  Outcome According to Elective Pelvic Radiation Therapy in Patients With High-Risk Localized Prostate Cancer: A Secondary Analysis of the GETUG 12 Phase 3 Randomized Trial.

Authors:  Pierre Blanchard; Laura Faivre; François Lesaunier; Naji Salem; Nathalie Mesgouez-Nebout; Elisabeth Deniau-Alexandre; Frédéric Rolland; Jean-Marc Ferrero; Nadine Houédé; Loïc Mourey; Christine Théodore; Ivan Krakowski; Jean-François Berdah; Marjorie Baciuchka; Brigitte Laguerre; Jean-Louis Davin; Muriel Habibian; Stéphane Culine; Agnès Laplanche; Karim Fizazi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-09-25       Impact factor: 7.038

3.  An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions.

Authors:  Colleen A Lawton; Michelle DeSilvio; Mack Roach; Valery Uhl; Robert Kirsch; Michael Seider; Marvin Rotman; Christopher Jones; Sucha Asbell; Richard Valicenti; Stephen Hahn; Charles R Thomas
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-05-24       Impact factor: 7.038

4.  Survival Outcomes of Whole-Pelvic Versus Prostate-Only Radiation Therapy for High-Risk Prostate Cancer Patients With Use of the National Cancer Data Base.

Authors:  Arya Amini; Bernard L Jones; Norman Yeh; Chad G Rusthoven; Hirotatsu Armstrong; Brian D Kavanagh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-09-18       Impact factor: 7.038
  4 in total
  5 in total

1.  Phase 1/2 Dose-Escalation Study of the Use of Intensity Modulated Radiation Therapy to Treat the Prostate and Pelvic Nodes in Patients With Prostate Cancer.

Authors:  Miguel Reis Ferreira; Atia Khan; Karen Thomas; Lesley Truelove; Helen McNair; Annie Gao; Chris C Parker; Robert Huddart; Margaret Bidmead; Ros Eeles; Vincent Khoo; Nicholas J van As; Vibeke N Hansen; David P Dearnaley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-08-02       Impact factor: 7.038

2.  Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL).

Authors:  David Dearnaley; Clare L Griffin; Rebecca Lewis; Philip Mayles; Helen Mayles; Olivia F Naismith; Victoria Harris; Christopher D Scrase; John Staffurth; Isabel Syndikus; Anjali Zarkar; Daniel R Ford; Yvonne L Rimmer; Gail Horan; Vincent Khoo; John Frew; Ramachandran Venkitaraman; Emma Hall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-12-06       Impact factor: 7.038

3.  Pelvic nodal radiotherapy in Gleason grade group 5 prostate cancer.

Authors:  Kiri Cook; Amar U Kishan
Journal:  Transl Androl Urol       Date:  2020-10

4.  A Prospective Study of Stereotactic Body Radiotherapy (SBRT) with Concomitant Whole-Pelvic Radiotherapy (WPRT) for High-Risk Localized Prostate Cancer Patients Using 1.5 Tesla Magnetic Resonance Guidance: The Preliminary Clinical Outcome.

Authors:  Darren M C Poon; Jing Yuan; Bin Yang; Oi-Lei Wong; Sin-Ting Chiu; George Chiu; Kin-Yin Cheung; Siu-Ki Yu; Raymond W H Yung
Journal:  Cancers (Basel)       Date:  2022-07-18       Impact factor: 6.575

5.  Individualized Dose-Escalation of HDR Prostate Brachytherapy Implant to Decrease Required External Beam Radiation Dose: A Retrospective Feasibility Study.

Authors:  Hannah M Dahn; Patricia A K Oliver; Stefan Allen; Amanda Cherpak; Alasdair Syme; Nikhilesh Patil; David Bowes
Journal:  Adv Radiat Oncol       Date:  2019-05-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.